17 Mar 2017

How To Campaign For Cannabis Law Reform Under A Theresa May Government.

    + Lobbying Parliament   + If the Government Won't Regulate Cannabis Then We'll Do It For Them   + The CBD Market   + Medical Cannabis   + Educating And Influencing Researchers   For cannabis and drugs policy reform, out of 650 MPs, there could not have been a worse person to seize power than Theresa May.  There are a few who come close on both Tory and Labour benches but no one who has such a long record of bigotry, denial of evidence and refusal even to consider the subject. [caption id="attachment_7621"...

31 Jan 2017

The UK Government’s Very Last Excuse For Denying Access To Medicinal Cannabis.

Essentially, UK government policy on cannabis hasn't altered since 1971.  Despite the vast amount of new evidence published since then and revolutionary change, particularly on medicinal use, all across the world, successive governments have stubbornly and obstinately refused to consider any sort of reform. It doesn't matter which party has been in power, Conservative, Labour or the coalition, it's a subject that ministers and MPs simply refuse to engage with.  It's easier that way for them and be in no doubt: laziness,...

08 Jan 2017

WARNING. So-Called ‘Indica’ CBD Products Are Illegal.

Any CBD products marketed in the UK as derived from 'indica' cannabis are illegal and you could be prosecuted for possession, importation or supply as with any other form of prohibited cannabis. The situation which started last October with the MHRA trying to shut down marketing of CBD products arose because of irresponsible, cowboy companies making medicinal claims about their products.  It was well understood by all professional CBD companies that this would cause problems and indeed it has. Only the intervention of CLEAR...

06 Dec 2016

The Facts About CBD In The UK. December 2016.

On 3rd October 2016 the Medicines and Healthcare products Regulatory Agency (MHRA)  issued notices to a number of CBD suppliers stating that cannabidiol (CBD) was being designated as a medicine and that sale of all CBD products must stop within 28 days, ostensibly by the 1st November. A lot has happened since.  Most importantly, the Cannabis Trades Association UK (CTAUK) has been established to represent the industry and protect the interests of CBD consumers but there remains great confusion as to the legal status of CBD...

23 Nov 2016

Crispin Blunt Asks Parliamentary Question On Medicinal Cannabis, 22nd November 2016.

Q. To ask the Secretary of State for Health, whether (a) his Department and (b) the Medicine and Healthcare Products Regulatory Agency has reviewed the latest evidence, including evidence on different regulatory approaches in other jurisdictions, for the use of medical cannabis. A. The Medicines and Healthcare products Regulatory Agency (MHRA) reviews evidence submitted by a company seeking a marketing authorisation for a medicinal...

04 Nov 2016

Report Of Meeting With MHRA On Regulation of Cannabidiol (CBD).

Yesterday, 3rd November 2016, six delegates from the UK Cannabis Trade Association (UKCTA) met with Medicines and Health Products Regulatory Agency (MHRA) representatives at the agency's headquarters in Victoria. We were courteously received. The meeting was cordial, productive and enabled both sides to clarify their positions and better understand each other's perspective. In...

01 Nov 2016

MHRA Backtracking Super Fast On CBD Ban.

In advance of the meeting between the UK Cannabis Trade Association (UKCTA) and the MHRA on Thursday, there has been a flurry of activity which amounts to a climb down by the regulator. This statement was published on the MHRA website at lunchtime today. "Update 1 November 2016 An MHRA spokesperson said: While MHRA has given its opinion that products containing cannabidiol (CBD) used for medical purposes are medicines, we have also carefully considered the needs of individuals using CBD products to treat or manage the...

30 Oct 2016

UK Cannabis Trade Association Meeting With MHRA This Week.

After all the speculation, many misleading and false reports and a plethora of attempts to interpret the MHRA's actions concerning cannabidiol (CBD), this week the chips are down. On Thursday 3rd November, at MHRA headquarters in Victoria, six representatives of the UK Cannabis Trade Association (UKCTA) will sit down with those responsible for the agency's statements on CBD. We will be armed with counsel's opinion on the legality of the MHRA's action but most importantly we...

19 Oct 2016

MHRA Confirms Meeting With CBD Industry Representatives.

Today, the Medicines and Healthcare products Regulatory Agency (MHRA), has arranged a meeting with representatives from the UK Cannabis Trade Association (UKCTA) to discuss its designation of cannabidiol (CBD) as a medicine. A request for a meeting was was first made in writing on 20th September 2016, when the possibility of the MHRA's action was still little more than a rumour.  Nearly six weeks later, after repeated requests, complaints and lobbying from many companies, individuals and MPs, the meeting has been fixed for 3rd November...

15 Oct 2016

The British Medical Journal (BMJ) Features The CLEAR Medicinal Cannabis Campaign.

"Muddled thinking" over cannabis leaves patients in limbo, warn campaigners BMJ 2016; 355 doi: http://dx.doi.org/10.1136/bmj.i5556 (Published 14 October 2016) Cite this as: BMJ 2016;355:i5556 Download PDF here Companies selling cannabis based products have been told to remove them from the market within 28 days, after a review by the Medicines and Healthcare Products Regulatory Agency (MHRA) determined that they were medicinal products. Campaigners for cannabis law reform welcomed the recognition that cannabidiol (CBD) had medicinal properties but warned that...